Regulation of hepatocyte engraftment and proliferation after cytotoxic drug-induced perturbation of the rat liver

Transplantation

Volumn 80, Issue 5, 2005, Pages 653-659

  Kim, Kyung Sik ^a   Joseph, Brigid ^b   Inada, Mari ^b,c   Gupta, Sanjeev ^b  

^a Yonsei University College of Medicine   (South Korea)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Chemotherapeutic drugs; Hepatocyte; Liver

Indexed keywords

CARBON TETRACHLORIDE; CYTOTOXIC AGENT; DIPEPTIDYL PEPTIDASE IV; DOXORUBICIN; IRINOTECAN; VINCRISTINE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CELL COMPARTMENTALIZATION; CELL DIVISION; CELL PROLIFERATION; CELL SPECIFICITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG INDUCED DISEASE; ELECTRON MICROSCOPY; ENZYME DEFICIENCY; KUPFFER CELL; LIVER CELL; LIVER GRAFT; LIVER RESECTION; LIVER TOXICITY; LIVER TRANSPLANTATION; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD26; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CARBON TETRACHLORIDE; CELL DIVISION; DOXORUBICIN; ENDOTHELIUM; GRAFT SURVIVAL; HEPATECTOMY; HEPATITIS, TOXIC; HEPATOCYTES; KUPFFER CELLS; RATS; RATS, INBRED F344; RATS, MUTANT STRAINS; VINCRISTINE;

EID: 25444478612     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000173382.11916.bf     Document Type: Article

References (27)

1. Gupta S, Inada M, Joseph B, et al. Emerging insights into liver-directed cell therapy for genetic and acquired disorders. Transplant Immunol 2004; 12: 289-302.
2. Gupta S, Rajvanshi P, Lee C-D. Integration of transplanted hepatocytes in host liver plates demonstrated with dipeptidyl peptidase IV deficient rats. Proc Natl Acad Sci (USA) 1995; 92: 5860-5864.
3. Gupta S, Rajvanshi P, Sokhi RP, et al. Entry and integration of transplanted hepatocytes in liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology 1999; 29: 509-519.
4. Malhi H, Annamaneni P, Slehria S, et al. Cyclophosphamide disrupts hepatic sinusoidal endothelium and improves transplanted cell engraftment in rat liver. Hepatology 2002; 36: 112-121.
5. Joseph B, Malhi H, Bhargava KK, et al. Kupffer cells participate in early clearance of syngeneic hepatocytes transplanted in the rat liver. Gastroenterology 2002; 123: 1677-1685.
6. Sokhi RP, Rajvanshi P, Gupta S. Transplanted reporter cells help in defining onset of hepatocyte proliferation during the life of F344 rats. Am J Physiol Gastroint Liver Physiol 2000; 279: G631-G640.
7. Laconi E, Oren R, Mukhopahyay DK, et al. Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated withretrorsine. Am J Pathol 1998; 153: 319-329.
8. Guo D, Fu T, Nelson JA, et al. Liver repopulation after cell transplantation in mice treated with retrorsine and carbon tetrachloride. Transplantation 2002; 73: 1818-1824.
9. Oren R, Dabeva MD, Karnezis AN, et al. Role of thyroid hormone in stimulating liver repopulation in the rat by transplanted hepatocytes. Hepatology 1999; 30: 903-913.
10. Guha C, Sharma A, Gupta S, et al. Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res 1999; 59: 5871-5874.
11. Malhi H, Gorla GR, Irani AN, et al. Cell transplantation after oxidative hepatic preconditioning with radiation and ischemia-reperfusion leads to extensive liver repopulation. Proc Natl Acad Sci USA 2002; 99: 13114-13119.
12. Qu X, Wan C, Becker HC, et al. The anticancer drug-DNA complex: femtosecond primary dynamics for anthracycline antibiotics function. Proc Natl Acad Sci USA 2001; 98: 14212-14217.
13. Spencer DM, Cutts SM, Kimura K, et al. Detection of labile anthracycline-DNA adducts by real-time PCR. Oncol Res 2003; 13: 479-489.
14. Mizutani H, Oikawa S, Hiraku Y, et al. Distinct mechanisms of site-specific oxidative DNA damage by doxorubicin in the presence of copper(II) and NADPH-cytochrome P450 reductase. Cancer Sci 2003; 94: 686-691.
15. Rebbaa A, Zheng X, Chou PM, Mirkin BL. Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 2003; 22: 2805-2811.
16. Cunha KS, Reguly ML, Graf U, Rodrigues de Andrade HH. Comparison of camptothecin derivatives presently in clinical trials: genotoxic potency and mitotic recombination. Mutagenesis 2002; 17: 141-147.
17. Tiburi M, Reguly ML, Schwartsmann G, et al. Comparative genotoxic effect of vincristine, vinblastine, and vinorelbine in somatic cells of Drosophila melanogaster. Mutat Res 2002; 519: 141-149.
18. Thompson NL, Hixson DC, Callanan H, et al. A Fischer rat substrain deficient in dipeptidyl peptidase IV activity makes normal steady-state RNA levels and an altered protein. Use as a liver-cell transplantation model. Biochem J 1991; 273: 497-502.
19. Tsuji E, Misumi Y, Fujiwara T, et al. An active-site mutation (Gly→Arg) of dipeptidyl peptidase IV causes its retention and rapid degradation in the endoplasmic reticulum. Biochem 1992; 31: 11921-11927.
20. Gupta S, Vasa SRG, Rajvanshi P, et al. Analysis of hepatocyte distribution and survival in vascular beds with cells marked by 99m-Tc or endogenous dipeptidyl peptidase IV activity. Cell Transplant 1997; 6: 377-386.
21. Sigal SH, Rajvanshi P, Gorla GR, et al. Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events. Am J Physiol 1999; 276: G1260-G1272.
22. Gupta S, Rajvanshi P, Aragona E, et al. Transplanted hepatocytes proliferate differently after CCl4 treatment and hepatocyte growth factor infusion. Am J Physiol 1999; 276: G629-G638.
23. Kasahara Y, Kiyatake K, Tatsumi K, et al. Bioactivation of monocrotaline by P-450 3A in rat liver. J Cardiovasc Pharmacol 1997; 30: 124-129.
24. Gordon GJ, Coleman WB, Grisham JW. Induction of cytochrome P450 enzymes in the livers of rats treated with the pyrrolizidine alkaloid retrorsine. Exp Mol Pathol 2000; 69: 17-26.
25. Rajvanshi P, Kerr A, Bhargava KK, et al. Efficacy and safety of repeated hepatocyte transplantation for significant liver repopulation in rodents. Gastroenterology 1996; 111: 1092-1102.
26. Miranda CJ, Makui H, Soares RJ, et al. Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin. Blood 2003; 102: 2574-2580.
27. Hazar V, Kutluk T, Akyuz C, et al. Veno-occlusive disease-like hepatotoxicity in two children receiving chemotherapy for Wilms' tumor and clear cell sarcoma of kidney. Pediatr Hematol Oncol 1998; 15: 85-89.